Holen Sie sich die Stockscreener-App
24.91
1.01%
-0.255
Handel nachbörslich:
24.93
0.025
+0.10%
Schlusskurs vom Vortag:
$25.16
Offen:
$25.22
24-Stunden-Volumen:
7,065
Relative Volume:
0.36
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.95%
1M Leistung:
-1.52%
6M Leistung:
-14.83%
1J Leistung:
-10.35%
1-Tages-Spanne:
$24.80
$25.22
1-Wochen-Bereich:
$24.33
$25.64
52-Wochen-Spanne:
$23.97
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Firmenname
Tema Oncology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CANC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
24.91 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
271.18 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
551.42 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
554.06 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
217.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
468.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Aktie (CANC) Neueste Nachrichten
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(CANC) Technical Data - Stock Traders Daily
When (CANC) Moves Investors should Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
(CANC) Long Term Investment Analysis - Stock Traders Daily
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World
Reshoring ETF Gets Boost From Trump Trade - etf.com
Long Term Trading Analysis for (CANC) - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat
(CANC) Technical Pivots with Risk Controls - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
(CANC) Trading Advice - Stock Traders Daily
Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World
National Bankshares Cuts Lucero Energy (CVE:LOU) Price Target to C$0.75 - Defense World
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
11 Best Biotech ETFs To Buy - Yahoo Finance
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Sanofi CEO under pressure to woo investors after spending shock - Reuters.com
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters.com
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch
This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - etf.com
Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Finanzdaten der Tema Oncology Etf-Aktie (CANC)
Es liegen keine Finanzdaten für Tema Oncology Etf (CANC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
Kapitalisierung:
|
Volumen (24h):